BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 23622515)

  • 1. A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression.
    Schachter MM; Merrick KA; Larochelle S; Hirschi A; Zhang C; Shokat KM; Rubin SM; Fisher RP
    Mol Cell; 2013 Apr; 50(2):250-60. PubMed ID: 23622515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
    Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
    PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
    Bockstaele L; Bisteau X; Paternot S; Roger PP
    Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
    Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
    Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.
    Larochelle S; Merrick KA; Terret ME; Wohlbold L; Barboza NM; Zhang C; Shokat KM; Jallepalli PV; Fisher RP
    Mol Cell; 2007 Mar; 25(6):839-50. PubMed ID: 17386261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
    Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
    J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase.
    Paternot S; Bockstaele L; Bisteau X; Kooken H; Coulonval K; Roger PP
    Cell Cycle; 2010 Feb; 9(4):689-99. PubMed ID: 20107323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes.
    Ray A; James MK; Larochelle S; Fisher RP; Blain SW
    Mol Cell Biol; 2009 Feb; 29(4):986-99. PubMed ID: 19075005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity.
    Wohlbold L; Larochelle S; Liao JC; Livshits G; Singer J; Shokat KM; Fisher RP
    Cell Cycle; 2006 Mar; 5(5):546-54. PubMed ID: 16552187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
    Matsuoka M; Kato JY; Fisher RP; Morgan DO; Sherr CJ
    Mol Cell Biol; 1994 Nov; 14(11):7265-75. PubMed ID: 7935441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
    Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M
    Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
    Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S
    Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of CAK kinase activity by p53.
    Schneider E; Montenarh M; Wagner P
    Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells.
    Merrick KA; Larochelle S; Zhang C; Allen JJ; Shokat KM; Fisher RP
    Mol Cell; 2008 Dec; 32(5):662-72. PubMed ID: 19061641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Cdk7/cyclin H/MAT1 the genuine cdk activating kinase in cycling Xenopus egg extracts?
    Fesquet D; Morin N; Doree M; Devault A
    Oncogene; 1997 Sep; 15(11):1303-7. PubMed ID: 9315098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice thrive without Cdk4 and Cdk2.
    Barrière C; Santamaría D; Cerqueira A; Galán J; Martín A; Ortega S; Malumbres M; Dubus P; Barbacid M
    Mol Oncol; 2007 Jun; 1(1):72-83. PubMed ID: 19383288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.